RVTY — Revvity Inc · catalysts, narrative & risks

Revvity Inc. (NYSE: RVTY) — Point-in-Time Snapshot (as of ~Oct 2–4, 2026)

As of the most recent close (Oct 2, 2026), RVTY traded near $151 with a market cap of ~$16.9B, up roughly +57% year-to-date and +66% over 12 months against a 52-week range of $81.22–$158.28 [9], [11], [13], [18]. The company (formerly PerkinElmer) is a life sciences and diagnostics provider serving pharma, biotech, academic, and clinical markets [9], [19], [20].

Recent Catalysts (last ~1–3 months)